RECURRENT OVARIAN CANCER
Clinical trials for RECURRENT OVARIAN CANCER explained in plain language.
Never miss a new study
Get alerted when new RECURRENT OVARIAN CANCER trials appear
Sign up with your email to follow new studies for RECURRENT OVARIAN CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for hard-to-treat ovarian cancer: drug combo shows promise in trial
Disease control CompletedThis study tested a new drug, relacorilant, combined with a standard chemotherapy (nab-paclitaxel) in 178 women with ovarian, fallopian tube, or peritoneal cancer that came back and no longer responds to platinum-based chemo. The goal was to see if the combination helps keep the …
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated May 17, 2026 03:19 UTC
-
Could a cholesterol drug slow ovarian cancer? small study tests the idea.
Disease control CompletedThis early-phase study tested whether adding simvastatin, a common cholesterol-lowering drug, to standard chemotherapy could help control platinum-sensitive ovarian cancer. 18 women with recurrent disease took part. The main goal was to see if patients could stick with the simvas…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: EARLY_PHASE1 • Sponsor: Marc Goodman • Aim: Disease control
Last updated May 08, 2026 12:02 UTC
-
New drug combo shows promise for tough ovarian cancer
Disease control CompletedThis early-stage trial tested whether adding a new drug called LDE225 to the standard chemotherapy paclitaxel is safe for women with ovarian cancer that no longer responds to platinum-based treatments. Fifteen women participated. The main goal was to check for side effects and fi…
Matched conditions: RECURRENT OVARIAN CANCER
Phase: PHASE1 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 04, 2026 16:21 UTC